Indeed, both DUX4 and PAX7 signatures showed only low-moderate FSHD classifier performance in Receiver Operator Characteristic (ROC) analysis (Fig. 2c), indicating that without additional biopsy selection criteria both signatures can only be detected in a subset of FSHD muscle biopsies. This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.